A bill to promote competition in the market for drugs and biological products by facilitating the timely entry of lower-cost generic and biosimilar versions of those drugs and biological products.

Action history

1. 2019-02-06Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 22.
2. 2019-02-05Introduced in Senate
3. 2019-02-05Introduced in the Senate. Read the first time. Placed on Senate Legislative Calendar under Read the First Time.